A detailed history of Russell Investments Group, Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 129,264 shares of REGN stock, worth $92.4 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
129,264
Previous 126,748 1.99%
Holding current value
$92.4 Million
Previous $133 Million 2.01%
% of portfolio
0.2%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1024.09 - $1201.76 $2.58 Million - $3.02 Million
2,516 Added 1.99%
129,264 $136 Million
Q2 2024

Aug 08, 2024

SELL
$883.2 - $1071.19 $1.56 Million - $1.89 Million
-1,763 Reduced 1.37%
126,748 $133 Million
Q1 2024

May 08, 2024

BUY
$902.69 - $993.35 $6.75 Million - $7.43 Million
7,481 Added 6.18%
128,511 $124 Million
Q4 2023

Feb 05, 2024

SELL
$775.18 - $881.7 $4.01 Million - $4.56 Million
-5,171 Reduced 4.1%
121,030 $106 Million
Q3 2023

Nov 13, 2023

BUY
$692.45 - $844.37 $243,742 - $297,218
352 Added 0.28%
126,201 $104 Million
Q2 2023

Aug 10, 2023

SELL
$700.03 - $830.35 $1.86 Million - $2.2 Million
-2,653 Reduced 2.06%
125,849 $90.4 Million
Q1 2023

May 09, 2023

SELL
$680.49 - $826.97 $4.27 Million - $5.19 Million
-6,275 Reduced 4.66%
128,502 $106 Million
Q4 2022

Feb 08, 2023

SELL
$705.89 - $766.39 $22.7 Million - $24.7 Million
-32,205 Reduced 19.29%
134,777 $97.2 Million
Q3 2022

Nov 04, 2022

BUY
$573.97 - $724.32 $3.66 Million - $4.61 Million
6,369 Added 3.97%
166,982 $115 Million
Q2 2022

Jul 29, 2022

SELL
$548.35 - $738.84 $14.6 Million - $19.6 Million
-26,577 Reduced 14.2%
160,613 $95.2 Million
Q1 2022

May 05, 2022

SELL
$595.12 - $698.43 $14.8 Million - $17.4 Million
-24,865 Reduced 11.73%
187,190 $131 Million
Q4 2021

Jan 21, 2022

BUY
$543.48 - $670.97 $3.32 Million - $4.1 Million
6,112 Added 2.97%
212,055 $134 Million
Q3 2021

Nov 08, 2021

BUY
$574.03 - $680.96 $9.82 Million - $11.6 Million
17,105 Added 9.06%
205,943 $125 Million
Q2 2021

Aug 04, 2021

BUY
$472.8 - $558.54 $11.7 Million - $13.8 Million
24,724 Added 15.07%
188,838 $105 Million
Q1 2021

May 10, 2021

BUY
$446.73 - $548.2 $14.9 Million - $18.3 Million
33,307 Added 25.46%
164,114 $77.5 Million
Q4 2020

Feb 08, 2021

BUY
$478.3 - $607.98 $1.9 Million - $2.41 Million
3,964 Added 3.13%
130,807 $63.1 Million
Q3 2020

Nov 09, 2020

SELL
$544.75 - $658.21 $5.26 Million - $6.35 Million
-9,649 Reduced 7.07%
126,843 $71.4 Million
Q2 2020

Aug 05, 2020

BUY
$493.32 - $643.92 $8.05 Million - $10.5 Million
16,325 Added 13.59%
136,492 $84.8 Million
Q1 2020

May 06, 2020

BUY
$336.18 - $494.43 $2.28 Million - $3.35 Million
6,783 Added 5.98%
120,167 $58.6 Million
Q4 2019

Jan 29, 2020

SELL
$274.13 - $376.51 $12.5 Million - $17.2 Million
-45,670 Reduced 28.71%
113,384 $42.6 Million
Q3 2019

Nov 01, 2019

BUY
$273.46 - $318.39 $16.8 Million - $19.5 Million
61,276 Added 62.67%
159,054 $44.1 Million
Q2 2019

Aug 09, 2019

SELL
$299.6 - $414.82 $6.22 Million - $8.61 Million
-20,747 Reduced 17.5%
97,778 $30.6 Million
Q1 2019

May 13, 2019

BUY
$372.08 - $439.57 $10.7 Million - $12.7 Million
28,802 Added 32.1%
118,525 $48.6 Million
Q4 2018

Feb 11, 2019

SELL
$335.82 - $403.04 $5.69 Million - $6.83 Million
-16,945 Reduced 15.89%
89,723 $33.4 Million
Q3 2018

Oct 26, 2018

BUY
$351.14 - $408.51 $6.58 Million - $7.66 Million
18,742 Added 21.32%
106,668 $43.1 Million
Q2 2018

Aug 08, 2018

SELL
$284.6 - $344.99 $27.2 Million - $33 Million
-95,630 Reduced 52.1%
87,926 $30.3 Million
Q1 2018

May 11, 2018

BUY
$315.82 - $393.78 $4.67 Million - $5.82 Million
14,776 Added 8.75%
183,556 $62.8 Million
Q4 2017

Feb 06, 2018

BUY
$358.63 - $469.95 $1.46 Million - $1.92 Million
4,084 Added 2.48%
168,780 $64.6 Million
Q3 2017

Nov 07, 2017

BUY
$431.38 - $504.0 $71 Million - $83 Million
164,696
164,696 $73.6 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.